Clinical Trial Update: Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluates a neoantigen vaccine plus anti-PD1 therapy and chemotherapy as adjuvant treatment for pancreatic cancer and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Anti-PD1 therapy
• Chemotherapy (chemotherapy)
• Neoantigen vaccine

Snippet

Sponsor: Sichuan University | Conditions: Pancreatic Cancer, Adjuvant Therapy | Phase 1 | Status: RECRUITING